Lexology January 10, 2024
McCarthy Tétrault LLP

The US Food and Drug Administration (“FDA”) announced last Friday that it had approved a drug importation program proposed by Florida’s Agency for Health Care Administration under section 804 of the Federal Food, Drug and Cosmetic Act . Through this section 804 importation program (also called a “SIP” under the implementing rule, 21 CFR 251), Florida is authorized to import certain eligible prescription drugs from Canada; however, trade is a two-way street. In response, Health Canada released a statement on January 8, 2024 that the Government of Canada was “taking all necessary action to safeguard the drug supply and ensure Canadians have access to the prescription drugs they need”.

Drugs that are eligible to be imported to Florida, according to...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech, States
Nevada announces intent to award Medicaid contracts
Where Medicaid Budget Cuts Would Hit Hardest
Trump blesses Medicaid scrutiny to pay for mega-MAGA package
Medicaid Waiver Tracker: Approved and Pending Section 1115 Waivers by State - 3
OpenAI calls for US to centralize AI regulation

Share This Article